UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:December 01,
Indaptus Therapeutics (NASDAQ:INDP)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Indaptus Therapeutics Charts.
Indaptus Therapeutics (NASDAQ:INDP)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Indaptus Therapeutics Charts.

Indaptus Therapeutics, Inc. News

Indaptus Therapeutics to Present Positive Data on Lead Product Candidate, Decoy20, at STING & TLR-Targeted Therapies Summit
Tuesday 11 June 2024 (1 month ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 8 June 2024 (1 month ago) • Edgar (US Regulatory)
Form 8-K - Current report
Saturday 8 June 2024 (1 month ago) • Edgar (US Regulatory)
Indaptus Therapeutics to Present New Positive Data on Decoy20 at Next-Gen Immuno-Oncology Conference
Tuesday 4 June 2024 (2 months ago) • GlobeNewswire Inc.
Indaptus Therapeutics Announces New Positive Data from Ongoing Phase 1 Trial of Decoy20
Monday 3 June 2024 (2 months ago) • GlobeNewswire Inc.
Indaptus Therapeutics to Present at the Jefferies Global Healthcare Conference
Thursday 30 May 2024 (2 months ago) • GlobeNewswire Inc.
Indaptus Therapeutics to Present New Cohort Data Confirming Original “Pulse-Prime” Hypothesis Via Phase 1 Clinical Trial of Decoy20 at the American Society of Clinical Oncology Annual Meeting
Wednesday 29 May 2024 (2 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Wednesday 22 May 2024 (2 months ago) • Edgar (US Regulatory)
Indaptus Therapeutics Announces Completion of First Patient to Receive Multiple Doses of Decoy20, the Company’s Broad-Based, “Pulse-Prime” Immuno-Oncology Therapy for Advanced Solid Tumors
Wednesday 22 May 2024 (2 months ago) • GlobeNewswire Inc.
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 8 May 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 8 May 2024 (2 months ago) • Edgar (US Regulatory)
Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Wednesday 8 May 2024 (2 months ago) • GlobeNewswire Inc.

More Indaptus Therapeutics, Inc. News Articles

Your Recent History

NEO
FCNS
Fidelity All In One Cons...
NYSE
BKN
BlackRock Investment Qua...
Delayed Upgrade Clock